ArticleIJTLD open2026

Breaking barriers in extensively drug-resistant TB: pretomanid-centred long regimen achieves cure in a bedaquiline-resistant strain.

M Schiuma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.